期刊文献+

糖尿病周围神经病的发病机制及治疗展望 被引量:31

Pathogenesis of Diabetic Peripheral Neuropathy and Prospect of Antioxidative Therapy
原文传递
导出
摘要 糖尿病周围神经病(DPN)是常见的糖尿病并发症。发病机制主要有多元醇途径的激活、糖基化终末产物的形成、蛋白激酶C途径的激活、氨基己糖途径的激活、线粒体内氧自由基过量生成的共同病理生理学机制以及氧自由基直接损伤机制等6个方面。抗氧化治疗是目前临床主要的治疗手段。以阻断共病机制为靶点的药物是今后的研究方向。本文主要针对DPN的发病机制及治疗等研究进展作介绍。 Diabetic peripheral neuropathy is one of the most common microvascular complications of diabetes mellitus. Recent evidences show that oxidative stress plays a key role in the development of diabetic neuropathy. Mechanisms that mediate the tissue-damaging effects of hyperglycemia include: enhancing of polyol pathway, intracellular production of advanced glycation end products, PKC activation, increased hexosamine pathway activity, over production of mitochondrial superoxide and direct damaging. It is concluded that conventional antioxidative therapies are essential and effective, while novel antioxidants are promising too. The unifying mechanism is a target for further study.
出处 《中国临床神经科学》 2008年第2期204-207,共4页 Chinese Journal of Clinical Neurosciences
关键词 糖尿病周围神经病 氧化应激 抗氧化治疗 diabetic peripheral neuropathy oxidative stress antioxidative therapy
  • 相关文献

参考文献30

  • 1Candrilli SD, Davis KL, Kan HJ, et al. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy[J]. J Diabetes Complications, 2007, 21: 306-314
  • 2Sasaki H, Schmelzer JD, Zollman PJ, et al. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats[J].Acta Neuropathol, 1997, 93:118-128
  • 3van Dam PS, van Asbeck BS, Bravenboer B, et al. Nerve function and oxidative stress in diabetic and vitamin E-deficient rats[J].Free Radic Biol Med, 1998, 24: 18-26
  • 4Fernyhough P, Huang TJ, Verkhratsky A. Mechanism of mitochondrial dysfunction in diabetic sensory neuropathy[J]. J Peripher Nerv Syst, 2003, 8:227-235
  • 5Schmeichel AM, Schmelzer JD, Low PA. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy[J]. Diabetes, 2003, 52: 165-171
  • 6Brownlee M. Biochemistry and molecular cell biology of diabetic complications[J]. Nature, 2001, 414:813-820
  • 7Oates PJ. Polyol pathway and diabetic peripheral neuropathy[J]. Int Rev Neurobiol, 2002, 50: 325-392
  • 8Deuther-Conrad W, Loske C, Schinzel R, et al. Advanced glycation end products change glutathione redos status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanism [J]. Neurosci Lett, 2001, 312:29-32
  • 9Thomas MC, Baynes JW, Thorpe SR, et al. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease[J]. Curr Drug Targets, 2005, 6:453-474
  • 10Kishikawa H, Mine S, Kawahara C, et al. Glycated albumin and cross-linking of CD44 induce scavenger receptor expression and uptake of oxidized LDL in human monocytes[J]. Biochem Biophys Res Commun, 2006, 339:846-851

同被引文献300

引证文献31

二级引证文献228

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部